Vol 10, No 1 (February 2021): Chinese Clinical Oncology

Review Article

Epidemiology, mutational landscape and staging of hepatocellular carcinoma
Sarah E. Fenton, Michael C. Burns, Aparna Kalyan
Imaging diagnosis of hepatocellular carcinoma: LI-RADS
Guilherme Moura Cunha, Claude B. Sirlin, Kathryn J. Fowler
The optimal timing and management of hepatitis B and C in patients with hepatocellular carcinoma
Thuy-Van P. Hang, Joel P. Wedd
Surgical resection of early stage hepatocellular carcinoma: balancing tumor biology with the host liver
Michelle R. Ju, Adam C. Yopp
Liver transplantation: expanding the donor and recipient pool
Ola Ahmed, M. B. Majella Doyle
Neoadjuvant and adjuvant treatment approaches for hepatocellular carcinoma: future outlook
Ibrahim Halil Sahin, Lana Khalil, Ralph Millett, Ahmed Kaseb
Liver-directed therapy for hepatocellular carcinoma
Cathal O’Leary, Mary Mahler, Michael C. Soulen
Efficacy and safety of radiotherapy for primary liver cancer
Wenqi Chen, Chi-Leung Chiang, Laura A. Dawson
Systemic therapy for advanced hepatocellular carcinoma: targeted therapies
Sri Harsha Tella, Anuhya Kommalapati, Amit Mahipal
Immunotherapy and chimeric antigen receptor T-cell therapy in hepatocellular carcinoma
Pedro Luiz Serrano Uson Junior, Alex J. Liu, Mohamad Bassam Sonbol, Mitesh J. Borad, Tanios S. Bekaii-Saab
Hepatocellular carcinoma, novel therapies on the horizon
Imane El Dika, Iman Makki, Ghassan K. Abou-Alfa